{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T16:01:00Z","timestamp":1792080060322,"version":"4.4.0"},"reference-count":21,"publisher":"Bioscientifica","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["edm.bioscientifica.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,1,1]]},"abstract":"<jats:sec>\n                    <jats:title>Summary<\/jats:title>\n                    <jats:p>Oral levothyroxine (LT4) is prescribed worldwide for hypothyroidism. Bariatric surgery for patients with obesity has shown a substantial, long-term weight loss and considerable improvement of obesity-related diseases. LT4 malabsorption represents a significant cause of refractory hypothyroidism, well known after malabsorptive bariatric surgery such as Roux-en-Y gastric bypass. However, few studies have shown an increase in oral LT4 needed after sleeve gastrectomy. We present a 47-year-old woman with class III obesity and a history of papillary thyroid cancer, with an excellent biochemical and structural response after total thyroidectomy and radioactive iodine. She underwent sleeve gastrectomy 3 years later and developed refractory hypothyroidism despite taking high doses of oral LT4 and ensuring compliance. The T4 absorption test confirmed gastrointestinal LT4 malabsorption. She was initiated on intramuscular LT4 and oral T3 (liothyronine) with improving symptoms and levels of thyroid-stimulating hormone.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Learning points<\/jats:title>\n                    <jats:list list-type=\"bullet\">\n                      <jats:list-item>\n                        <jats:p>Monitoring thyroid function tests is essential after bariatric surgery, including sleeve gastrectomy.<\/jats:p>\n                      <\/jats:list-item>\n                      <jats:list-item>\n                        <jats:p>Oral LT4 malabsorption should be considered in cases of refractory hypothyroidism.<\/jats:p>\n                      <\/jats:list-item>\n                      <jats:list-item>\n                        <jats:p>The T4 absorption test is a useful tool for distinguishing true malabsorption from pseudo-malabsorption.<\/jats:p>\n                      <\/jats:list-item>\n                      <jats:list-item>\n                        <jats:p>Decreased LT4 absorption after bariatric surgery might be explained by higher gastric pH and reduced stomach volume (impaired dissolution) and by interference with food, vitamin\/mineral supplements or other drugs.<\/jats:p>\n                      <\/jats:list-item>\n                      <jats:list-item>\n                        <jats:p>When LT4 malabsorption is confirmed, a trial of other oral formulations (LT4 tablet crushed, soft gel or liquid preparation) or parenteral administrations is suggested.<\/jats:p>\n                      <\/jats:list-item>\n                    <\/jats:list>\n                  <\/jats:sec>","DOI":"10.1530\/edm-24-0115","type":"journal-article","created":{"date-parts":[[2025,1,27]],"date-time":"2025-01-27T06:43:25Z","timestamp":1737960205000},"update-policy":"https:\/\/doi.org\/10.1530\/crossmarkpolicy-2","source":"Crossref","is-referenced-by-count":2,"title":["Levothyroxine malabsorption following sleeve gastrectomy"],"prefix":"10.1530","volume":"2025","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-3761-7772","authenticated-orcid":true,"given":"Elodie","family":"Gruneisen","sequence":"first","affiliation":[{"name":"Division of Endocrinology, McGill University Health Centre, Montreal, Canada"},{"name":"Division of Endocrinology, Diabetology and Metabolism, Department of Medicine, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji Wei","family":"Yang","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, McGill University Health Centre, Montreal, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2389-9066","authenticated-orcid":true,"given":"Melissa-Rosina","family":"Pasqua","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, McGill University Health Centre, Montreal, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"416","reference":[{"key":"bib1","series-title":"Surg Obes Relat Dis","first-page":"333","article-title":"Oral levothyroxine therapy postbariatric surgery: biopharmaceutical aspects and clinical effects","volume":"15","author":"Azran C","year":"2019","unstructured":"Azran C\n, \nPorat D\n, \nFine-Shamir N\n, et al.\n Oral levothyroxine therapy postbariatric surgery: biopharmaceutical aspects and clinical effects. Surg Obes Relat Dis 2019 15 333\u2013341. (https:\/\/doi.org\/10.1016\/j.soard.2019.01.001)"},{"key":"bib2","series-title":"Obes Surg","first-page":"782","article-title":"Bariatric surgery worldwide: baseline demographic description and one-year outcomes from the fourth IFSO global registry report 2018","volume":"29","author":"Welbourn R","year":"2019","unstructured":"Welbourn R\n, \nHollyman M\n, \nKinsman R\n, et al.\n Bariatric surgery worldwide: baseline demographic description and one-year outcomes from the fourth IFSO global registry report 2018. Obes Surg 2019 29 782\u2013795. (https:\/\/doi.org\/10.1007\/s11695-018-3593-1)"},{"key":"bib3","series-title":"Canadian Adult Obesity Clinical Practice Guidelines","article-title":"Bariatric Surgery: Surgical Options and Outcomes. In:","author":"Biertho L","year":"2020","unstructured":"Biertho L\n, \nHong D\n & \nGagner M\n\n. Bariatric Surgery: Surgical Options and Outcomes. In:. Canadian Adult Obesity Clinical Practice Guidelines 2020. (https:\/\/obesitycanada.ca\/guidelines\/surgeryoptions)"},{"key":"bib4","series-title":"Lancet","first-page":"293","article-title":"Metabolic surgery versus conventional medical therapy in patients with type 2 diabetes: 10-year follow-up of an open-label, single-centre, randomised controlled trial","volume":"397","author":"Mingrone G","year":"2021","unstructured":"Mingrone G\n, \nPanunzi S\n, \nDe Gaetano A\n, et al.\n Metabolic surgery versus conventional medical therapy in patients with type 2 diabetes: 10-year follow-up of an open-label, single-centre, randomised controlled trial. Lancet 2021 397 293\u2013304. (https:\/\/doi.org\/10.1016\/s0140-6736(20)32649-0)"},{"key":"bib5","series-title":"Surg Obes Relat Dis","first-page":"1576","article-title":"Obstructive sleep apnea remission following bariatric surgery: a national registry cohort study","volume":"17","author":"Currie AC","year":"2021","unstructured":"Currie AC\n, \nKaur V\n, \nCarey I\n, et al.\n Obstructive sleep apnea remission following bariatric surgery: a national registry cohort study. Surg Obes Relat Dis 2021 17 1576\u20131582. (https:\/\/doi.org\/10.1016\/j.soard.2021.05.021)"},{"key":"bib6","series-title":"Thyroid","first-page":"1670","article-title":"Guidelines for the treatment of hypothyroidism: prepared by the american thyroid association task force on thyroid hormone replacement","volume":"24","author":"Jonklaas J","year":"2014","unstructured":"Jonklaas J\n, \nBianco AC\n, \nBauer AJ\n, et al.\n Guidelines for the treatment of hypothyroidism: prepared by the american thyroid association task force on thyroid hormone replacement. Thyroid 2014 24 1670\u20131751. (https:\/\/doi.org\/10.1089\/thy.2014.0028)"},{"key":"bib7","series-title":"Endocr Rev","first-page":"118","article-title":"Gastrointestinal malabsorption of thyroxine","volume":"40","author":"Virili C","year":"2019","unstructured":"Virili C\n, \nAntonelli A\n, \nSantaguida MG\n, et al.\n Gastrointestinal malabsorption of thyroxine. Endocr Rev 2019 40 118\u2013136. (https:\/\/doi.org\/10.1210\/er.2018-00168)"},{"key":"bib8","series-title":"Front Endocrinol","article-title":"Levothyroxine therapy in gastric malabsorptive disorders","volume":"11","author":"Virili C","year":"2021","unstructured":"Virili C\n, \nBrusca N\n, \nCapriello S\n, et al.\n Levothyroxine therapy in gastric malabsorptive disorders. Front Endocrinol 2021 11 621616. (https:\/\/doi.org\/10.3389\/fendo.2020.621616)"},{"key":"bib9","series-title":"J Endocrinol Invest","first-page":"1289","article-title":"Diagnosis and management of treatment-refractory hypothyroidism: an expert consensus report","volume":"40","author":"Centanni M","year":"2017","unstructured":"Centanni M\n, \nBenvenga S\n & \nSachmechi I\n\n. Diagnosis and management of treatment-refractory hypothyroidism: an expert consensus report. J Endocrinol Invest 2017 40 1289\u20131301. (https:\/\/doi.org\/10.1007\/s40618-017-0706-y)"},{"key":"bib10","series-title":"Eur J Endocrinol","first-page":"913","article-title":"A thyroxine absorption test followed by weekly thyroxine administration: a method to assess non-adherence to treatment","volume":"168","author":"Walker JN","year":"2013","unstructured":"Walker JN\n, \nShillo P\n, \nIbbotson V\n, et al.\n A thyroxine absorption test followed by weekly thyroxine administration: a method to assess non-adherence to treatment. Eur J Endocrinol 2013 168 913\u2013917. (https:\/\/doi.org\/10.1530\/eje-12-1035)"},{"key":"bib11","series-title":"CMAJ","first-page":"205","article-title":"Treatment-refractory hypothyroidism","volume":"184","author":"Ramadhan A","year":"2012","unstructured":"Ramadhan A\n & \nTamilia M\n\n. Treatment-refractory hypothyroidism. CMAJ 2012 184 205\u2013209. (https:\/\/doi.org\/10.1503\/cmaj.110994)"},{"key":"bib12","series-title":"Front Pharmacol","article-title":"Effects of bariatric surgery on drug pharmacokinetics-preclinical studies","volume":"14","author":"Mercado A","year":"2023","unstructured":"Mercado A\n, \nPham A\n, \nWang Z\n, et al.\n Effects of bariatric surgery on drug pharmacokinetics-preclinical studies. Front Pharmacol 2023 14 1133415. (https:\/\/doi.org\/10.3389\/fphar.2023.1133415)"},{"key":"bib13","series-title":"Obes Surg","first-page":"97","article-title":"Effect of weight loss after bariatric surgery on thyroid-stimulating hormone levels in patients with morbid obesity and normal thyroid function","volume":"28","author":"Neves JS","year":"2018","unstructured":"Neves JS\n, \nCastro Oliveira S\n, \nSouteiro P\n, et al.\n Effect of weight loss after bariatric surgery on thyroid-stimulating hormone levels in patients with morbid obesity and normal thyroid function. Obes Surg 2018 28 97\u2013103. (https:\/\/doi.org\/10.1007\/s11695-017-2792-5)"},{"key":"bib14","series-title":"Obes Surg","first-page":"2000","article-title":"The impact of bariatric surgery on thyroid function and medication use in patients with hypothyroidism","volume":"27","author":"Zendel A","year":"2017","unstructured":"Zendel A\n, \nAbu-Ghanem Y\n, \nDux J\n, et al.\n The impact of bariatric surgery on thyroid function and medication use in patients with hypothyroidism. Obes Surg 2017 27 2000\u20132004. (https:\/\/doi.org\/10.1007\/s11695-017-2616-7)"},{"key":"bib15","series-title":"Obes Surg","first-page":"1493","article-title":"Oral liquid L-thyroxine (L-t4) may be better absorbed compared to L-T4 tablets following bariatric surgery","volume":"23","author":"Pirola I","year":"2013","unstructured":"Pirola I\n, \nFormenti AM\n, \nGandossi E\n, et al.\n Oral liquid L-thyroxine (L-t4) may be better absorbed compared to L-T4 tablets following bariatric surgery. Obes Surg 2013 23 1493\u20131496. (https:\/\/doi.org\/10.1007\/s11695-013-1015-y)"},{"key":"bib16","series-title":"Endocr Rev","first-page":"393","article-title":"Levothyroxine: conventional and novel drug delivery formulations","volume":"44","author":"Liu H","year":"2023","unstructured":"Liu H\n, \nLi W\n, \nZhang W\n, et al.\n Levothyroxine: conventional and novel drug delivery formulations. Endocr Rev 2023 44 393\u2013416. (https:\/\/doi.org\/10.1210\/endrev\/bnac030)"},{"key":"bib17","series-title":"Proc (Bayl Univ Med Cent)","first-page":"38","article-title":"Hypothyroidism following gastric sleeve surgery resolved by ingesting crushed thyroxine tablets","volume":"33","author":"Fain K","year":"2020","unstructured":"Fain K\n, \nRojas AP\n & \nPeiris AN\n\n. Hypothyroidism following gastric sleeve surgery resolved by ingesting crushed thyroxine tablets. Proc (Bayl Univ Med Cent) 2020 33 38\u201339. (https:\/\/doi.org\/10.1080\/08998280.2019.1669412)"},{"key":"bib18","series-title":"Expert Opin Drug Deliv","first-page":"647","article-title":"Advancements in the treatment of hypothyroidism with L-T4 liquid formulation or soft gel capsule: an update","volume":"14","author":"Fallahi P","year":"2017","unstructured":"Fallahi P\n, \nFerrari SM\n, \nRuffilli I\n, et al.\n Advancements in the treatment of hypothyroidism with L-T4 liquid formulation or soft gel capsule: an update. Expert Opin Drug Deliv 2017 14 647\u2013655. (https:\/\/doi.org\/10.1080\/17425247.2016.1227782)"},{"key":"bib19","series-title":"Curr Opin Endocrinol Diabetes Obes","first-page":"318","article-title":"Alternative routes of levothyroxine administration for hypothyroidism","volume":"27","author":"Ritter MJ","year":"2020","unstructured":"Ritter MJ\n, \nGupta S\n & \nHennessey JV\n\n. Alternative routes of levothyroxine administration for hypothyroidism. Curr Opin Endocrinol Diabetes Obes 2020 27 318\u2013322. (https:\/\/doi.org\/10.1097\/med.0000000000000558)"},{"key":"bib20","series-title":"Clin Endocrinol","first-page":"206","article-title":"Use of liothyronine (T3) in hypothyroidism: joint British Thyroid Association\/Society for endocrinology consensus statement","volume":"99","author":"Ahluwalia R","year":"2023","unstructured":"Ahluwalia R\n, \nBaldeweg SE\n, \nBoelaert K\n, et al.\n Use of liothyronine (T3) in hypothyroidism: joint British Thyroid Association\/Society for endocrinology consensus statement. Clin Endocrinol 2023 99 206\u2013216. (https:\/\/doi.org\/10.1111\/cen.14935)"},{"key":"bib21","series-title":"Endocr J","first-page":"469","article-title":"Successful treatment of myxedema coma with a combination of levothyroxine and liothyronine","volume":"66","author":"Ueda K","year":"2019","unstructured":"Ueda K\n, \nKiyota A\n, \nTsuchida M\n, et al.\n Successful treatment of myxedema coma with a combination of levothyroxine and liothyronine. Endocr J 2019 66 469\u2013474. (https:\/\/doi.org\/10.1507\/endocrj.ej18-0469)"}],"container-title":["Endocrinology, Diabetes &amp; Metabolism Case Reports"],"original-title":[],"link":[{"URL":"https:\/\/edm.bioscientifica.com\/view\/journals\/edm\/2025\/1\/EDM-24-0115.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/edm.bioscientifica.com\/downloadpdf\/journals\/edm\/2025\/1\/EDM-24-0115.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/edm.bioscientifica.com\/downloadpdf\/journals\/edm\/2025\/1\/EDM-24-0115.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T13:48:30Z","timestamp":1784555310000},"score":1,"resource":{"primary":{"URL":"http:\/\/journals.bioscientifica.com\/edm\/article\/3749"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,1]]},"references-count":21,"journal-issue":{"issue":"1"},"URL":"https:\/\/doi.org\/10.1530\/edm-24-0115","relation":{},"ISSN":["2052-0573"],"issn-type":[{"value":"2052-0573","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,1]]}}}